Eli Lilly stocks displayed a major rise after the announcement of a new oral weight-loss drug that has put pressure on its ...

Gloperba® is the first and only liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in ...

It used to be available as the brand-name drug Zofran. Ondansetron comes as an oral tablet and orally ... Note: After the Food and Drug Administration (FDA) approves a drug, it tracks and reviews ...

People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...

Merck & Co.'s peptides could be undergoing a transformation into oral tablets thanks to a $493 million licensing deal the ...

The Drug Delivery Devices Market segmentation, based on route of administration, includes oral, ocular, inhalation, nasal, injectable, topical, and others. Oral segment dominated the global market in ...

Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that ... through the required pre-clinical studies and eventually to Food and Drug Administration applications.

Eli Lilly stocks displayed a major rise after the announcement of a new oral weight-loss drug that has put pressure ... depending on dosage. Analysts noted the company plans to submit full trial ...

The original PROOF-HD trial of pridopidine was negative, but a new analysis showed it has clinically meaningful effects in ...

The drugmaker Lilly announced topline results of a clinical trial of a new pill in the same drug class as injectables like ...

Accent Therapeutics has dosed the first subject in an open-label Phase I/II trial of ATX-295, an oral kinesin family member ...